“This workshop was an important forum for sharing the successes and challenges encountered during the implementation of the RTS,s vaccine in the pilot countries, as well as defining the way forward for its development and use.”
- Professor Oumar Gaye

• To provide up to date information on the vaccine efficacy and safety as well as joint implementation of Seasonal Malaria Chemoprevention and RTS,s vaccine.
• To foster exchanges between countries that have piloted the introduction of the RTS,S malaria vaccine in routine child. immunization services and countries that have not yet done so to better understand practical implementation challenges. 
• To discuss availability plans of RTS,S for the coming years.

Report     [English]   [French]

Presentations:

RTS,S evidence, including efficacy, safety, feasibility and impact – speaker: Dr Mary HAMEL (WHO MVIP, IVB)   [English]   [French]

Efficacy and safety of combining the seasonal use of RTS,S malaria vaccine and Seasonal Malaria Chemoprevention (SMC) – speaker: Professor Alassane DICKO (MRTC, Mali)  [English]  [French]

Lessons learned in terms of practical experience from pilot introduction of the RTS,S malaria vaccine in routine child immunization programmes:

• In Kenya – speaker: Dr George GITHUKA (NMCP, Kenya) / Dr Rose JALANG’O (NVIP, Kenya)  [English]  [French]
• In Ghana – speaker: Dr Kwame AMPONSA-ACHEANO (EPI, Ghana)  [English]   [French]  
• In Malawi – speaker: Mr John SANDE (NMCP, Malawi) / Mr Mtenje (EPI, Malawi)   [English]  [French]
  

Facilitators and barriers for differential uptake of RTS,S Doses 0-4: Evidence from child caregiver cohort from Ghana, Kenya, and Malawi – speaker: Dr Jessica PRICE (PATH)  [English]  [French]

Next steps for the malaria vaccine for broader deployment – speaker: Dr Mgaywa MAGAFU (MVIP, AFRO)  [English]